Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM)

被引：0
|
作者：
Jun Du
Zheng Lin
Xue-Hang Fu
Xiao-Ran Gu
Guang Lu
Jian Hou
机构：
[1] Shanghai Jiao Tong University,Department of Hematology, Renji Hospital, School of Medicine
[2] Shanghai Jiao Tong University School of Medicine,Department of Hematology
[3] Shengli Oilfield Central Hospital,undefined
来源：
Cell Communication and Signaling | / 22卷
关键词：
Chemokines; Multiple Myeloma (MM); CAR-T cell therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
    Philipp-Abbrederis, Kathrin
    Herrmann, Ken
    Knop, Stefan
    Schottelius, Margret
    Eiber, Matthias
    Lueckerath, Katharina
    Pietschmann, Elke
    Habringer, Stefan
    Gerngross, Carlos
    Franke, Katharina
    Rudelius, Martina
    Schirbel, Andreas
    Lapa, Constantin
    Schwamborn, Kristina
    Steidle, Sabine
    Hartmann, Elena
    Rosenwald, Andreas
    Kropf, Saskia
    Beer, Ambros J.
    Peschel, Christian
    Einsele, Hermann
    Buck, Andreas K.
    Schwaiger, Markus
    Goetze, Katharina
    Wester, Hans-Juergen
    Keller, Ulrich
    EMBO MOLECULAR MEDICINE, 2015, 7 (04) : 477 - 487
  • [32] Gambogic acid inhibits chemokine receptor CXCR4 signaling pathways and osteoclastogenesis in multiple myeloma
    Pandey, Manoj K.
    Kale, Vijay P.
    Song, Chunhua
    Sung, Shen-Shu
    Sharma, Arun K.
    Dovat, Sinisa
    Amin, Shantu G.
    CANCER RESEARCH, 2014, 74 (19)
  • [33] Chemokine receptor antagonism as a new therapy for multiple sclerosis
    Ransohoff, RM
    Bacon, KB
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (05) : 1079 - 1097
  • [34] Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells in vivo
    Zeissig, Mara N.
    Hewett, Duncan R.
    Panagopoulos, Vasilios
    Mrozik, Krzysztof M.
    To, L. Bik
    Croucher, Peter I.
    Zannettino, Andrew C. W.
    Vandyke, Kate
    HAEMATOLOGICA, 2021, 106 (12) : 3176 - 3187
  • [35] Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines
    Zeissig, Mara N.
    Hewett, Duncan R.
    Mrozik, Krzysztof M.
    Panagopoulos, Vasilios
    Wallington-Gates, Craig T.
    Spencer, Andrew
    Dold, Sandra M.
    Engelhardt, Monika
    Vandyke, Kate
    Zannettino, Andrew C. W.
    LEUKEMIA RESEARCH, 2024, 139
  • [36] Multiple talents of the chemokine receptor-CXCR4
    Desjardins, Sonia F.
    Berchiche, Yamina A.
    Haddad, Elie
    Heveker, Nikolaus
    M S-MEDECINE SCIENCES, 2007, 23 (11): : 980 - 984
  • [37] Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis
    Sorensen, TL
    Ransohoff, RM
    Strieter, RM
    Sellebjerg, F
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 (07) : 445 - 449
  • [38] The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients
    Cao, Yanran
    Luetkens, Tim
    Kobold, Sebastian
    Hildebrandt, York
    Gordic, Maja
    Lajmi, Nesrine
    Meyer, Sabrina
    Bartels, Katrin
    Zander, Axel R.
    Bokemeyer, Carsten
    Kroeger, Nicolaus
    Atanackovic, Djordje
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (10) : 860 - 867
  • [39] Altered cytokine and chemokine profiles in multiple myeloma and its precursor disease
    Zingone, Adriana
    Wang, Weixin
    Corrigan-Cummins, Meghan
    Wu, S. Peter
    Plyler, Ryan
    Korde, Neha
    Kwok, Mary
    Manasanch, Elisabet E.
    Tageja, Nishant
    Bhutani, Manisha
    Mulquin, Marcia
    Zuchlinski, Diamond
    Yancey, Mary Ann
    Roschewski, Mark
    Zhang, Yong
    Roccaro, Aldo M.
    Ghobrial, Irene M.
    Calvo, Katherine R.
    Landgren, Ola
    CYTOKINE, 2014, 69 (02) : 294 - 297
  • [40] CXCL13 CHEMOKINE - A NOVEL TARGET IN MULTIPLE MYELOMA MICROENVIRONMENT
    Beider, K.
    Voevoda, V.
    Bitner, H.
    Rosenberg, E.
    Ostrovsky, O.
    Ribakovsky, E.
    Leiba, M.
    Shimoni, A.
    Koren-Michowitz, M.
    Abraham, M.
    Peled, A.
    Nagler, A.
    HAEMATOLOGICA, 2016, 101 : 250 - 250
12345